Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F3P2C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,956
Award facts
- Contract value 100% obligated
- $28,956.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $28,956.01 by the Defense Logistics Agency (DLA) on December 31, 2025, with an ultimate completion date of January 2, 2026. The contract is for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units and utilizes firm fixed pricing with no set-aside designation. This award represents a competitively awarded delivery order executed under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company serves as a prime vendor under the DLA's Pharmaceutical Prime Vendor Global Program, which enables it to deliver medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency operations and other government healthcare systems worldwide. This particular delivery order for Biktarvy, an antiretroviral medication, reflects the company's ongoing role in supplying essential pharmaceutical commodities to federal healthcare programs on a firm fixed price basis.
Quick answers
Who was awarded contract SPE2DR26F3P2C?
SPE2DR26F3P2C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26F3P2C worth?
The government has obligated $28,956 on SPE2DR26F3P2C.
Is contract SPE2DR26F3P2C an order under another contract?
Yes. SPE2DR26F3P2C is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3P2C competed?
The extent of competition for SPE2DR26F3P2C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award